Atıf Formatları
COVID-19 AND DERMATOLOGY (PART II): ADVERSE MUCOCUTANEOUS REACTIONS TO MEDICATIONS AND VACCINES USED FOR COVID-19 INFECTION
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

D. Özkaya And G. ERFAN, "COVID-19 AND DERMATOLOGY (PART II): ADVERSE MUCOCUTANEOUS REACTIONS TO MEDICATIONS AND VACCINES USED FOR COVID-19 INFECTION," ACTA MEDICA MEDITERRANEA , vol.38, no.2, pp.1051-1059, 2022

Özkaya, D. And ERFAN, G. 2022. COVID-19 AND DERMATOLOGY (PART II): ADVERSE MUCOCUTANEOUS REACTIONS TO MEDICATIONS AND VACCINES USED FOR COVID-19 INFECTION. ACTA MEDICA MEDITERRANEA , vol.38, no.2 , 1051-1059.

Özkaya, D., & ERFAN, G., (2022). COVID-19 AND DERMATOLOGY (PART II): ADVERSE MUCOCUTANEOUS REACTIONS TO MEDICATIONS AND VACCINES USED FOR COVID-19 INFECTION. ACTA MEDICA MEDITERRANEA , vol.38, no.2, 1051-1059.

Özkaya, DİLEK, And GAMZE ERFAN. "COVID-19 AND DERMATOLOGY (PART II): ADVERSE MUCOCUTANEOUS REACTIONS TO MEDICATIONS AND VACCINES USED FOR COVID-19 INFECTION," ACTA MEDICA MEDITERRANEA , vol.38, no.2, 1051-1059, 2022

Özkaya, DİLEK B. And ERFAN, GAMZE. "COVID-19 AND DERMATOLOGY (PART II): ADVERSE MUCOCUTANEOUS REACTIONS TO MEDICATIONS AND VACCINES USED FOR COVID-19 INFECTION." ACTA MEDICA MEDITERRANEA , vol.38, no.2, pp.1051-1059, 2022

Özkaya, D. And ERFAN, G. (2022) . "COVID-19 AND DERMATOLOGY (PART II): ADVERSE MUCOCUTANEOUS REACTIONS TO MEDICATIONS AND VACCINES USED FOR COVID-19 INFECTION." ACTA MEDICA MEDITERRANEA , vol.38, no.2, pp.1051-1059.

@article{article, author={DİLEK BIYIK ÖZKAYA And author={GAMZE ERFAN}, title={COVID-19 AND DERMATOLOGY (PART II): ADVERSE MUCOCUTANEOUS REACTIONS TO MEDICATIONS AND VACCINES USED FOR COVID-19 INFECTION}, journal={ACTA MEDICA MEDITERRANEA}, year=2022, pages={1051-1059} }